Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	3.40e-05	2	117	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	3.40e-05	2	117	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	3.40e-05	2	117	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	3.40e-05	2	117	2	GO:0004354
GeneOntologyMolecularFunction	structural constituent of nuclear pore	NUP107 NUP205 NUP133	4.10e-04	25	117	3	GO:0017056
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	7.01e-04	7	117	2	GO:0070728
MousePheno	abnormal body length	DYM STARD4 SPTAN1 KDM3B CHD2 GRIK3 ZFC3H1 MREG PPP2R2A NUP133 GREB1 BCAR3 GNL1 CSGALNACT1 DEUP1	2.76e-06	550	92	15	MP:0001256
MousePheno	decreased body length	DYM STARD4 SPTAN1 KDM3B CHD2 GRIK3 MREG PPP2R2A NUP133 GREB1 BCAR3 GNL1 CSGALNACT1 DEUP1	3.12e-06	484	92	14	MP:0001258
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	3.82e-05	2	116	2	PF02812
Domain	Uncharacterised_TMEM39	TMEM39B TMEM39A	3.82e-05	2	116	2	IPR019397
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	3.82e-05	2	116	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	3.82e-05	2	116	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	3.82e-05	2	116	2	IPR006095
Domain	Tmp39	TMEM39B TMEM39A	3.82e-05	2	116	2	PF10271
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.82e-05	2	116	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	3.82e-05	2	116	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	3.82e-05	2	116	2	PS00074
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.82e-05	2	116	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	3.82e-05	2	116	2	IPR033524
Domain	-	PLXNA3 FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A NUP133 PLXNA1	4.35e-05	333	116	10	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	PLXNA3 FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A NUP133 PLXNA1	4.58e-05	335	116	10	IPR015943
Domain	PP2A_PR55_CS	PPP2R2D PPP2R2A	2.28e-04	4	116	2	IPR018067
Domain	PP2A_PR55	PPP2R2D PPP2R2A	2.28e-04	4	116	2	IPR000009
Domain	PR55_2	PPP2R2D PPP2R2A	2.28e-04	4	116	2	PS01025
Domain	PR55_1	PPP2R2D PPP2R2A	2.28e-04	4	116	2	PS01024
Domain	IPT	PLXNA3 PKHD1L1 PLXNA1	6.12e-04	27	116	3	SM00429
Domain	TIG	PLXNA3 PKHD1L1 PLXNA1	9.24e-04	31	116	3	PF01833
Domain	IPT	PLXNA3 PKHD1L1 PLXNA1	1.02e-03	32	116	3	IPR002909
Domain	Plexin_cytopl	PLXNA3 PLXNA1	1.34e-03	9	116	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNA1	1.34e-03	9	116	2	IPR013548
Domain	Plexin	PLXNA3 PLXNA1	1.34e-03	9	116	2	IPR031148
Domain	WD_REPEATS_1	FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A	1.76e-03	278	116	7	PS00678
Domain	WD_REPEATS_2	FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A	1.80e-03	279	116	7	PS50082
Domain	WD_REPEATS_REGION	FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A	1.80e-03	279	116	7	PS50294
Domain	-	ABCA2 NWD1 DYNC2H1 ABCA13 RNF213 CHD2 AK3 DNAH1 ORC5 SAMD9L GNL1 NLRP4	2.33e-03	746	116	12	3.40.50.300
Domain	P-loop_NTPase	ABCA2 NWD1 KIF1A DYNC2H1 ABCA13 RNF213 CHD2 AK3 DNAH1 ORC5 SAMD9L GNL1 NLRP4	2.33e-03	848	116	13	IPR027417
Domain	ABC_A	ABCA2 ABCA13	2.42e-03	12	116	2	IPR026082
Domain	WD40_repeat_dom	FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A	2.55e-03	297	116	7	IPR017986
Domain	ZF_RING_2	TRIM49D1 RNF213 ZSWIM2 ARIH2 UBR3 TRIM38 TRIM37	2.60e-03	298	116	7	PS50089
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH1	3.31e-03	14	116	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH1	3.31e-03	14	116	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH1	3.31e-03	14	116	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH1	3.31e-03	14	116	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH1	3.31e-03	14	116	2	IPR011704
Domain	MT	DYNC2H1 DNAH1	3.31e-03	14	116	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH1	3.31e-03	14	116	2	PF12780
Domain	AAA_5	DYNC2H1 DNAH1	3.31e-03	14	116	2	PF07728
Domain	DHC_fam	DYNC2H1 DNAH1	3.81e-03	15	116	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH1	3.81e-03	15	116	2	PF03028
Domain	PI3/4_kinase_CS	PIK3CD ATM	3.81e-03	15	116	2	IPR018936
Domain	Dynein_heavy_dom	DYNC2H1 DNAH1	3.81e-03	15	116	2	IPR004273
Domain	Znf_RING	TRIM49D1 RNF213 ZSWIM2 ARIH2 UBR3 TRIM38 TRIM37	4.26e-03	326	116	7	IPR001841
Domain	-	PIK3CD ATM	4.34e-03	16	116	2	1.10.1070.11
Domain	PI3Kc	PIK3CD ATM	4.34e-03	16	116	2	SM00146
Domain	-	PLXNA3 RASA2	4.34e-03	16	116	2	1.10.506.10
Domain	ARM-type_fold	USP34 VEPH1 HEATR1 PIK3CD NOC4L ATM TARBP1	5.26e-03	339	116	7	IPR016024
Domain	PI3_PI4_kinase	PIK3CD ATM	5.48e-03	18	116	2	PF00454
Domain	PI3_4_KINASE_1	PIK3CD ATM	5.48e-03	18	116	2	PS00915
Domain	PI3_4_KINASE_2	PIK3CD ATM	5.48e-03	18	116	2	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3CD ATM	5.48e-03	18	116	2	IPR000403
Domain	RasGAP_dom	PLXNA3 RASA2	5.48e-03	18	116	2	IPR001936
Domain	PI3_4_KINASE_3	PIK3CD ATM	5.48e-03	18	116	2	PS50290
Domain	WD40	FBXW10B FBXW10 NWD1 PPP2R2D WDR19 PPP2R2A	5.60e-03	259	116	6	PF00400
Domain	CARBOXYPEPT_ZN_2	CPD AGBL2	6.10e-03	19	116	2	PS00133
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	GLUD1 GLUD2 GABPA	3.03e-05	11	82	3	MM14866
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 NUP107 NCKAP1 KIF1A NPEPPS SPTAN1 NOL6 CHD2 HEATR1 URB2 NUP205 NUP133 NOC4L ATM	6.34e-08	653	120	14	22586326
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 ABCA2 KIF1A SPTAN1 HECTD4 NCAPH2 ZFC3H1 ZKSCAN5 TERF2IP WDR19 FRY ARIH2 GLUD1 FMN2 ATM CABIN1 TARBP1 TRIM37 KLHL4	9.02e-08	1285	120	19	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 ABCA2 ZSCAN12 PPP2R2D VPS13C HECTD4 KDM3B NUP205 WDR19 PPP2R2A ATP11B ESPL1	3.23e-07	529	120	12	14621295
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PLXNA3 USP34 ABCA2 GOLM2 ERO1A LAMA4 RNF213 CPD NCAPH2 LRP8 THEM6 PPP2R2A UGGT2 ATM CSGALNACT1 PLXNA1 CDON	8.41e-07	1201	120	17	35696571
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	NUP107 PPP2R2D DYNC2H1 NPEPPS NCAPH2 HEATR1 THEM6 ORC5 PPP2R2A GLUD1 GLUD2 NUP133	1.34e-06	606	120	12	36538041
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	USP34 KIF1A PPP2R2D NPEPPS ERO1A CPD NCAPH2 HEATR1 NUP205 THEM6 PPP2R2A PTPN14 GLUD1 NUP133 ESPL1	1.41e-06	974	120	15	28675297
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	NUP107 NCKAP1 KIF1A DYNC2H1 NPEPPS VPS13C ERO1A SPTAN1 NOL6 HEATR1 URB2 NUP205 PPP2R2A GLUD1 NUP133 NOC4L ATM PLXNA1	1.96e-06	1425	120	18	30948266
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	PDE8A NUP107 NCKAP1 PPP2R2D DYNC2H1 DCTN2 NCAPH2 HEATR1 NUP205 WDR19 THEM6 PPP2R2A SLC9C1 PTPN14 NUP133 UGGT2 COL14A1	3.04e-06	1321	120	17	27173435
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NUP107 DYNC2H1 DCTN2 ERO1A SPTAN1 CPD HEATR1 ZFC3H1 WDR19 THEM6 PTPN14 GLUD1 NUP133 NOC4L UGGT2 COL14A1 ATM ESPL1	3.56e-06	1487	120	18	33957083
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	PLXNA3 FBXW10B ZSCAN12 KIF1A ABCA13 KDM3B MUC16 RNF213 GRIK3 HEATR1 ATP11B	3.56e-06	552	120	11	10737800
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DYM RASA2 KIF1A NPEPPS VPS13C GOLM2 HECTD4 RNF213 CHD2 CPD TERF2IP LRP8 DNAH1 PPP2R2A ATP11B GALNT11 GREB1 CSMD1	3.62e-06	1489	120	18	28611215
Pubmed	Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability.	PLXNA3 RET PLXNA1	8.61e-06	12	120	3	25839327
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	CCDC14 DYNC2H1 ERO1A NOL6 LAMA4 NLGN1 HEATR1 NOC4L	1.07e-05	302	120	8	30561431
Pubmed	Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	1.18e-05	2	120	2	15750346
Pubmed	Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.	GLUD1 GLUD2	1.18e-05	2	120	2	1711373
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	1.18e-05	2	120	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	1.18e-05	2	120	2	28621566
Pubmed	Purification, crystallization and preliminary X-ray analysis of a Nup107-Nup133 heterodimeric nucleoporin complex.	NUP107 NUP133	1.18e-05	2	120	2	17768364
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	1.18e-05	2	120	2	32078638
Pubmed	Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.	GLUD1 GLUD2	1.18e-05	2	120	2	20529287
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	1.18e-05	2	120	2	23595828
Pubmed	Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).	GLUD1 GLUD2	1.18e-05	2	120	2	25124006
Pubmed	Structural and functional analysis of Nup133 domains reveals modular building blocks of the nuclear pore complex.	NUP107 NUP133	1.18e-05	2	120	2	15557116
Pubmed	Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.	GLUD1 GLUD2	1.18e-05	2	120	2	23673664
Pubmed	Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.	GLUD1 GLUD2	1.18e-05	2	120	2	21621574
Pubmed	Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.	GLUD1 GLUD2	1.18e-05	2	120	2	39052831
Pubmed	Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.	GLUD1 GLUD2	1.18e-05	2	120	2	24442550
Pubmed	Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice.	USP34 ATM	1.18e-05	2	120	2	37043976
Pubmed	Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.	GLUD1 GLUD2	1.18e-05	2	120	2	28911206
Pubmed	Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization.	PGR GREB1	1.18e-05	2	120	2	28911214
Pubmed	Expression and alternative splicing of N-RAP during mouse skeletal muscle development.	NRAP NOL6	1.18e-05	2	120	2	18792955
Pubmed	The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.	GLUD1 GLUD2	1.18e-05	2	120	2	27137930
Pubmed	GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution.	GLUD1 GLUD2	1.18e-05	2	120	2	26440896
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	1.18e-05	2	120	2	31400758
Pubmed	Delineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase.	GLUD1 GLUD2	1.18e-05	2	120	2	22875990
Pubmed	Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme.	GLUD1 GLUD2	1.18e-05	2	120	2	12742085
Pubmed	Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.	GLUD1 GLUD2	1.18e-05	2	120	2	15578726
Pubmed	Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	1.18e-05	2	120	2	15044002
Pubmed	Induction of excitatory and inhibitory presynaptic differentiation by GluD1.	GLUD1 GLUD2	1.18e-05	2	120	2	22138648
Pubmed	Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.	GLUD1 GLUD2	1.18e-05	2	120	2	34220417
Pubmed	ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.	ERO1A MUC16	1.18e-05	2	120	2	33056994
Pubmed	Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues.	GLUD1 GLUD2	1.18e-05	2	120	2	26241911
Pubmed	Architectural nucleoporins Nup157/170 and Nup133 are structurally related and descend from a second ancestral element.	NUP107 NUP133	1.18e-05	2	120	2	19674973
Pubmed	Structural and functional studies of Nup107/Nup133 interaction and its implications for the architecture of the nuclear pore complex.	NUP107 NUP133	1.18e-05	2	120	2	18570875
Pubmed	Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.	GLUD1 GLUD2	1.18e-05	2	120	2	21446915
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	1.18e-05	2	120	2	37450367
Pubmed	Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive Darwinian selection.	GLUD1 GLUD2	1.18e-05	2	120	2	18688271
Pubmed	The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.	GLUD1 GLUD2	1.18e-05	2	120	2	22658952
Pubmed	GluD1 binds GABA and controls inhibitory plasticity.	GLUD1 GLUD2	1.18e-05	2	120	2	38060673
Pubmed	Two highly related regulatory subunits of PP2A exert opposite effects on TGF-beta/Activin/Nodal signalling.	PPP2R2D PPP2R2A	1.18e-05	2	120	2	18697906
Pubmed	Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice.	GLUD1 GLUD2	1.18e-05	2	120	2	24593767
Pubmed	Increases in anterograde axoplasmic transport in neurons of the hyper-glutamatergic, glutamate dehydrogenase 1 (Glud1) transgenic mouse: Effects of glutamate receptors on transport.	GLUD1 GLUD2	1.18e-05	2	120	2	38124277
Pubmed	Potentiation of neuronal activity by tonic GluD1 current in brain slices.	GLUD1 GLUD2	1.18e-05	2	120	2	37154294
Pubmed	Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis.	GLUD1 GLUD2	1.18e-05	2	120	2	19015267
Pubmed	Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.	GLUD1 GLUD2	1.18e-05	2	120	2	22924626
Pubmed	Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome.	NUP107 NUP133	1.18e-05	2	120	2	26411495
Pubmed	Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum.	GLUD1 GLUD2	1.18e-05	2	120	2	19448744
Pubmed	The conserved Nup107-160 complex is critical for nuclear pore complex assembly.	NUP107 NUP133	1.18e-05	2	120	2	12705868
Pubmed	Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.	GLUD1 GLUD2	1.18e-05	2	120	2	11032875
Pubmed	Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme.	GLUD1 GLUD2	1.18e-05	2	120	2	11950837
Pubmed	Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.	GLUD1 GLUD2	1.18e-05	2	120	2	29943084
Pubmed	The conserved transmembrane protein TMEM-39 coordinates with COPII to promote collagen secretion and regulate ER stress response.	TMEM39B TMEM39A	1.18e-05	2	120	2	33524011
Pubmed	Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.	GLUD1 GLUD2	1.18e-05	2	120	2	31898404
Pubmed	Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux.	GLUD1 GLUD2	1.18e-05	2	120	2	15378063
Pubmed	Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.	GLUD1 GLUD2	1.18e-05	2	120	2	27422263
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CCDC14 NUP107 PPP2R2D GOLM2 SPTAN1 RNF213 CPD PPP2R2A PTPN14 SSH3 NUP133 FMN2 UBR3 NOC4L	1.63e-05	1049	120	14	27880917
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	USP34 ZSCAN12 NUP107 NCKAP1 GOLM2 NOL6 CHD2 CPD HEATR1 URB2 ZFC3H1 NUP205 THEM6 ORC5 NOC4L	1.77e-05	1203	120	15	29180619
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	NUP107 NOL6 RNF213 HEATR1 URB2 NUP205 NUP133 NOC4L	2.11e-05	332	120	8	25693804
Pubmed	Multiple mouse chromosomal loci for dynein-based motility.	DYNC2H1 DCTN2 DNAH1 FUT4	2.14e-05	47	120	4	8812413
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NUP107 NCKAP1 KIF1A DYNC2H1 CPD HEATR1 URB2 NUP205 THEM6 NUP133 UGGT2 ESPL1 TARBP1	2.36e-05	942	120	13	31073040
Pubmed	Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses via Cbln2 and neurexin.	GLUD1 GLUD2	3.53e-05	3	120	2	29784783
Pubmed	Identification of plexin family molecules in mice.	PLXNA3 PLXNA1	3.53e-05	3	120	2	8806646
Pubmed	The structure of apo human glutamate dehydrogenase details subunit communication and allostery.	GLUD1 GLUD2	3.53e-05	3	120	2	12054821
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MUC16 PGR	3.53e-05	3	120	2	27163153
Pubmed	Trans-Synaptic Signaling through the Glutamate Receptor Delta-1 Mediates Inhibitory Synapse Formation in Cortical Pyramidal Neurons.	GLUD1 GLUD2	3.53e-05	3	120	2	31704028
Pubmed	Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.	GLUD1 GLUD2	3.53e-05	3	120	2	29229616
Pubmed	Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis.	GLUD1 GLUD2	3.53e-05	3	120	2	30002133
Pubmed	Cytoplasmic dynein promotes HIV-1 uncoating.	DYNC2H1 DCTN2	3.53e-05	3	120	2	25375884
Pubmed	Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens.	GLUD1 GLUD2	3.53e-05	3	120	2	30315226
Pubmed	Differential expression of plexin-A subfamily members in the mouse nervous system.	PLXNA3 PLXNA1	3.53e-05	3	120	2	11241833
Pubmed	Isolation of a human brain cDNA for glutamate dehydrogenase.	GLUD1 GLUD2	3.53e-05	3	120	2	3585334
Pubmed	GOT1 regulates CD8+ effector and memory T cell generation.	GLUD1 GLUD2	3.53e-05	3	120	2	36640309
Pubmed	Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes.	GLUD1 GLUD2	3.53e-05	3	120	2	37871770
Pubmed	Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.	GLUD1 GLUD2	3.53e-05	3	120	2	23560106
Pubmed	Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase.	GLUD1 GLUD2	3.53e-05	3	120	2	20670938
Pubmed	Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.	RET BCAR3	3.53e-05	3	120	2	35031902
Pubmed	Myeloid translocation gene 16b is a dual A-kinase anchoring protein that interacts selectively with plexins in a phospho-regulated manner.	PLXNA3 PLXNA1	3.53e-05	3	120	2	20138877
Pubmed	Identification of disulfide bond formation between MitoNEET and glutamate dehydrogenase 1.	GLUD1 GLUD2	3.53e-05	3	120	2	24295216
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 DYM DCTN2 NPEPPS ERO1A SPTAN1 NOL6 RNF213 HEATR1 NUP205 THEM6 PPP2R2A NUP133 NOC4L ATM CABIN1	3.69e-05	1440	120	16	30833792
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	ABHD17A PDE8A VPS13C URB2 PLEKHN1 LRP8 THEM6 ATP11B TMEM39A TARBP1 CSGALNACT1	4.12e-05	719	120	11	35337019
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PLXNA3 FBXW10B FBXW10 KDM3B CPD GCNT7 GALNT11 SSH3 ARIH2 FUT4 PLXNA1	4.73e-05	730	120	11	34857952
Pubmed	DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.	NUP107 DCTN2 NUP205 PPP2R2A NOC4L	5.76e-05	118	120	5	37105989
Pubmed	Enriched expression of GluD1 in higher brain regions and its involvement in parallel fiber-interneuron synapse formation in the cerebellum.	GLUD1 GLUD2	7.05e-05	4	120	2	24872547
Pubmed	An evolutionarily conserved NPC subcomplex, which redistributes in part to kinetochores in mammalian cells.	NUP107 NUP133	7.05e-05	4	120	2	11564755
Pubmed	Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.	GLUD1 GLUD2	7.05e-05	4	120	2	25721396
Pubmed	Chromosome assignment of four plexin A genes (Plxna1, Plxna2, Plxna3, Plxna4) in mouse, rat, Syrian hamster and Chinese hamster.	PLXNA3 PLXNA1	7.05e-05	4	120	2	11306810
Pubmed	PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure.	PLXNA3 PLXNA1	7.05e-05	4	120	2	25518740
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	DYNC2H1 RNF213	7.05e-05	4	120	2	26147384
Pubmed	The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.	GLUD1 GLUD2	7.05e-05	4	120	2	23663782
Pubmed	Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.	NUP107 NUP133	7.05e-05	4	120	2	30179222
Interaction	GPR182 interactions	ABCA2 DYM NCKAP1 RNF213 TMEM39B HEATR1 URB2 NUP205 THEM6 ATM FASTKD3 TARBP1 SEC14L1	2.22e-06	455	116	13	int:GPR182
Interaction	OPALIN interactions	DYM RNF213 TMEM39B HEATR1 URB2 PLEKHN1 NUP205 ATM TARBP1	3.41e-06	209	116	9	int:OPALIN
Interaction	CD70 interactions	DYM NUP107 HEATR1 NUP205 ORC5 NUP133 ATM SEC14L1	5.35e-06	166	116	8	int:CD70
Cytoband	11q22-q23	PGR ATM	1.01e-04	6	120	2	11q22-q23
GeneFamily	WD repeat domain containing	FBXW10B FBXW10 NWD1 PPP2R2D WDR19 WDR93 PPP2R2A	1.60e-04	262	80	7	362
GeneFamily	Nucleoporins	NUP107 NUP205 NUP133	3.77e-04	32	80	3	1051
GeneFamily	Plexins	PLXNA3 PLXNA1	6.82e-04	9	80	2	683
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10	1.04e-03	11	80	2	559
GeneFamily	ATP binding cassette subfamily A	ABCA2 ABCA13	1.70e-03	14	80	2	805
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R2D PPP2R2A	1.96e-03	15	80	2	696
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	DYM NUP107 SPTAN1 NOL6 RNF213 HEATR1 URB2 RET NUP205 MREG PIK3CD NUP133 ATM CABIN1 ESPL1 NLRP4 TCFL5 TRIM37	5.28e-07	810	118	18	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	CCDC14 DYM NUP107 ERO1A NOL6 HEATR1 URB2 NUP205 MREG ATP11B NUP133 ATM FASTKD3 ESPL1 NLRP4 TRIM37	8.45e-06	795	118	16	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
ToppCell	droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ABCA13 NPEPPS ERO1A ITIH5 MREG SAMD9L	7.24e-07	187	119	7	14c239af77116d28d511dea754b6150d20488080
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LAMA4 NLGN1 PGR PIEZO2 COL14A1 CSGALNACT1 KLHL4	9.27e-07	194	119	7	5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCKAP1 ABCA13 MUC16 CPD COL14A1 CSMD1 CDON	9.59e-07	195	119	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCKAP1 ABCA13 MUC16 CPD COL14A1 CSMD1 CDON	9.59e-07	195	119	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 VPS13C RNF213 CHD2 ZFC3H1 SAMD9L ATM	1.14e-06	200	119	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NWD1 DYNC2H1 ABCA13 MUC16 WDR93 AGBL2	6.28e-06	169	119	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLXNA3 ABCA13 ITIH5 WDR93 PLXNA1 CDON	8.18e-06	177	119	6	30f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 GRIK3 PKHD1L1 DNAH1 PIEZO2 CSMD1	1.02e-05	184	119	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 GRIK3 PKHD1L1 DNAH1 PIEZO2 CSMD1	1.02e-05	184	119	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 GRIK3 PKHD1L1 DNAH1 PIEZO2 CSMD1	1.02e-05	184	119	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Heart-LA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 PTPN14 ZBTB39 CSGALNACT1 TRIM37 KLHL4	1.05e-05	185	119	6	1ecfca049c0c1110fd1b2256db7cb7abda6afb04
ToppCell	facs-Heart-LA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 PTPN14 ZBTB39 CSGALNACT1 TRIM37 KLHL4	1.05e-05	185	119	6	b6df1412b579d40ed5df806f9c54bd1fbb9a1e15
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 LAMA4 PTPN14 ZBTB39 SMARCD3 TRIM37	1.05e-05	185	119	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.08e-05	186	119	6	40070d9cd20188ba49b32acfca9bc16256b38bf5
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.12e-05	187	119	6	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	Endothelial-B\|World / lung cells shred on cell class, cell subclass, sample id	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.15e-05	188	119	6	5959a88728812a5f4cbfa54eddc7a73ccbaa2f68
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.15e-05	188	119	6	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NWD1 LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.15e-05	188	119	6	524a12f433c7b6f33fad36c0716afa06cd3235e9
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NWD1 LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.15e-05	188	119	6	d2610b81b3c7f22977b5e2137b1f61410fc4ef16
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.15e-05	188	119	6	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.15e-05	188	119	6	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DYNC2H1 LAMA4 ITIH5 PGR PIEZO2 COL14A1	1.19e-05	189	119	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.22e-05	190	119	6	8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.22e-05	190	119	6	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.22e-05	190	119	6	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 FRY PTPN14 ZBTB39 CSGALNACT1 KLHL4	1.30e-05	192	119	6	14a816ef116aa992f86edab411f043cf7d07fe04
ToppCell	facs-Heart-LA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 FRY PTPN14 ZBTB39 CSGALNACT1 KLHL4	1.30e-05	192	119	6	847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	LAMA4 RET PKHD1L1 PIEZO2 PTPN14 KLHL4	1.34e-05	193	119	6	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.34e-05	193	119	6	040f6bb42aa41d0921371fdda1cc0912c4fe1930
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.34e-05	193	119	6	e468287c8b30c56d1de65e8347ade233ba6cf584
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A DYNC2H1 VPS13C RET MLXIPL FMN2	1.42e-05	195	119	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A DYNC2H1 VPS13C RET MLXIPL FMN2	1.42e-05	195	119	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.50e-05	197	119	6	407231542fa1ffd540dcb61435c0575e71f59725
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE8A NOL6 KDM3B ORC5 KLHL36	1.51e-05	116	119	5	f2bf9599040f43b5ea8724841d7b71c0a859c016
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.55e-05	198	119	6	5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 PKHD1L1 PIEZO2 PTPN14 CSGALNACT1 KLHL4	1.55e-05	198	119	6	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 SPTAN1 LAMA4 RNF213 CSGALNACT1 SEC14L1	1.64e-05	200	119	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NCKAP1 SPTAN1 ITIH5 FRY CSGALNACT1 SEC14L1	1.64e-05	200	119	6	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	pdx-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SPTAN1 TERF2IP IQCA1L PPP2R2A PTPN14	4.27e-05	144	119	5	0b94d978262a826c9254145aa98c6c30240243f9
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLXNA3 PGR SLC9C1 SMARCD3 CSMD1	4.56e-05	146	119	5	2ac9b487a7991fdc15444aeb93533030e09825bb
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9\|TCGA-Colorectal / Sample_Type by Project: Shred V9	GRIK3 NLGN1 PGR FMN2 CDON	6.83e-05	159	119	5	f376bf6cd0ed374211edac3c384f3a78f0caef2a
ToppCell	Endothelial-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	LAMA4 PKHD1L1 PTPN14 CSGALNACT1 KLHL4	8.14e-05	165	119	5	b6893882472aeb0d18e26f47eaec9d53688afcde
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIF1A GRIK3 RET FMN2 GREB1	8.61e-05	167	119	5	c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCell	390C-Lymphocytic-ILC-ILC-2\|390C / Donor, Lineage, Cell class and subclass (all cells)	IL12RB2 NLGN1 HEATR1 CD101 GNL1	8.86e-05	168	119	5	2781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCell	droplet-Fat-Bat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSCAN12 VPS13C TLR5 FUT4 ESPL1	8.86e-05	168	119	5	6fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCell	droplet-Fat-Bat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSCAN12 VPS13C TLR5 FUT4 ESPL1	8.86e-05	168	119	5	794035cb63353a7d02fd9939deb5b4d075c9d95a
ToppCell	droplet-Fat-Bat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZSCAN12 VPS13C TLR5 FUT4 ESPL1	8.86e-05	168	119	5	1e23b634f96e88b976a523ca1f3fc08f6fe9b239
ToppCell	Endothelial-B-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	8.86e-05	168	119	5	4977c3837fbb1f36c89fddd5764e37290ac25ad8
ToppCell	Endothelial-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	9.11e-05	169	119	5	95c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIF1A GRIK3 RET FMN2 GREB1	9.11e-05	169	119	5	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 VEPH1 NLGN1 PKHD1L1 DNAH1	9.11e-05	169	119	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	9.90e-05	172	119	5	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	LAMA4 PKHD1L1 ITIH5 PIEZO2 CSGALNACT1	9.90e-05	172	119	5	c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.02e-04	173	119	5	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	Endothelial-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.02e-04	173	119	5	a81992965137195d20fc498f750975303961a828
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZKSCAN5 PIK3CD CD101 NUP133 SMARCD3	1.07e-04	175	119	5	a2adaa09f37e3db5d819e56ed402fe04b72abeb2
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RNF213 SAMD9L SMARCD3 TRIM38 TARBP1	1.07e-04	175	119	5	97616bb5c127284aa9e67bc336dfcf29e137164b
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MUC16 LRRC2 PKHD1L1 BCAR3 ESPL1	1.07e-04	175	119	5	3b5346fba617292de71963b6175e85a4f182fe30
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 PKHD1L1 ITIH5 GCNT7 UGGT2	1.07e-04	175	119	5	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZKSCAN5 PIK3CD CD101 NUP133 SMARCD3	1.07e-04	175	119	5	59a8481a3b4ed63b137baea25bc02f2078dc3ac7
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 PKHD1L1 ITIH5 GCNT7 UGGT2	1.07e-04	175	119	5	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFC3H1 LRP8 MREG ORC5 TMEM39A	1.10e-04	176	119	5	24b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MUC16 LRRC2 PKHD1L1 BCAR3 ESPL1	1.10e-04	176	119	5	dc4e939a07bad21ab36181f9588df3fa662f9a92
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.10e-04	176	119	5	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.10e-04	176	119	5	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZFC3H1 LRP8 MREG ORC5 TMEM39A	1.13e-04	177	119	5	f360f7099570d248531897b96e0de282e58f59e9
ToppCell	RV-11._Adipocyte\|World / Chamber and Cluster_Paper	LAMA4 ITIH5 MREG FRMD4A MLXIPL	1.13e-04	177	119	5	f0edf04930692418953e4f00a917257804ec0ffd
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho\|lymph-node_spleen / Manually curated celltypes from each tissue	ZSCAN12 NCKAP1 NCAPH2 LRP8 GCNT7	1.13e-04	177	119	5	53040dbeb18574a48e352e4bce252c7c3018762c
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	LAMA4 ITIH5 MREG FRMD4A MLXIPL	1.16e-04	178	119	5	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.16e-04	178	119	5	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.16e-04	178	119	5	ad3de3e03a401dac64431a541899445262246347
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 NPEPPS MUC16 CHD2 PLEKHN1	1.19e-04	179	119	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLEKHN1 ITIH5 DNAH1 PTPN14 COL14A1	1.22e-04	180	119	5	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	RA-11._Adipocyte\|RA / Chamber and Cluster_Paper	LAMA4 ITIH5 MREG FRMD4A MLXIPL	1.22e-04	180	119	5	d48a3d27357f7d184132a6805950f93080146b59
ToppCell	COVID-19-Epithelial-Ionocytes\|Epithelial / Condition, Lineage and Cell class	LRRC2 URB2 RET ITIH5 SLC9C1	1.26e-04	181	119	5	4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCell	RV\|World / Chamber and Cluster_Paper	NRAP LAMA4 LRRC2 NLGN1 CSGALNACT1	1.26e-04	181	119	5	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 SPTAN1 RNF213 CHD2 ATM	1.26e-04	181	119	5	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA2 KIF1A RET PLEKHN1 LRP8	1.29e-04	182	119	5	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.29e-04	182	119	5	53c267ee327e116dbd89d5927ed3bdf78d25ee62
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 PKHD1L1 COL14A1 BCAR3 CDON	1.29e-04	182	119	5	9966f42c338cbd471efa8ffc765a6ce93693aa75
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.32e-04	183	119	5	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RNF213 TERF2IP GALNT11 ATM KLHL4	1.32e-04	183	119	5	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	(6)_Endothelial-F_(Lymphatics)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.36e-04	184	119	5	03ea613e00b45c81b752c14505a0538d698f551e
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF1A GRIK3 RET ESPL1 DEUP1	1.36e-04	184	119	5	d5e44c9085da2a46531ed6db1249bdd88c41b45c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC2 ITIH5 FRY PTPN14 FMN2	1.36e-04	184	119	5	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 PKHD1L1 ITIH5 PTPN14 KLHL4	1.39e-04	185	119	5	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.39e-04	185	119	5	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	NWD1 DYNC2H1 MUC16 WDR93 AGBL2	1.39e-04	185	119	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.39e-04	185	119	5	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 PKHD1L1 ITIH5 PTPN14 KLHL4	1.39e-04	185	119	5	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 SAMD9L PTPN14 TRIM37 KLHL4	1.43e-04	186	119	5	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	(4)_Lymph_vessel\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	LAMA4 PKHD1L1 PIEZO2 CSGALNACT1 KLHL4	1.43e-04	186	119	5	6b3afc2ae870ff73e30a60ce84fcee0eb365d809
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 NLGN1 PTPN14 COL14A1 CSGALNACT1	1.43e-04	186	119	5	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 PKHD1L1 PIEZO2 PTPN14 KLHL4	1.43e-04	186	119	5	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 CPD NLGN1 PTPN14 CSGALNACT1	1.46e-04	187	119	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 GRIK3 PKHD1L1 PIEZO2 KLHL4	1.46e-04	187	119	5	65d406122dffe18279f14a1ed35ba091730b97be
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 GRIK3 PKHD1L1 PIEZO2 KLHL4	1.46e-04	187	119	5	4c15c0ed41a55271fc793cb76fee97fa64190369
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 GRIK3 PKHD1L1 PIEZO2 KLHL4	1.46e-04	187	119	5	5274f2b302bbf7fed30c480af4f35058d2cf61e0
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 NPEPPS VPS13C RNF213 CHD2	1.50e-04	188	119	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VEPH1 LAMA4 RET ITIH5 COL14A1	1.50e-04	188	119	5	aa516273cdde53c8c0295f06830972388f890c97
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A	USP34 ABCA2 NCAPH2 WDR19 FRMD4A ARIH2 TLR5 GREB1 ATM PLXNA1 SEC14L1	3.82e-09	192	115	11	6809_DN
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ABCA2 KIF1A ZKSCAN5 FRMD4A ZBTB39 SSH3 ARIH2 GREB1 CABIN1 PLXNA1	5.76e-08	195	115	10	3508_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	PLXNA3 KIF1A DYNC2H1 ERO1A CPD NCAPH2 URB2 ARIH2 FUT4	6.92e-07	196	115	9	1543_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	USP34 KIF1A SPTAN1 NCAPH2 TLR5 ATM FUT4 CDON SEC14L1	8.19e-07	200	115	9	4824_DN
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A	ABCA2 ZKSCAN5 ORC5 PTPN14 ZBTB39 ARIH2 SMARCD3 ATM	6.78e-06	195	115	8	6082_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	USP34 ABCA2 ZSCAN12 URB2 RET PGR PTPN14 PLXNA1	7.31e-06	197	115	8	1635_UP
Drug	Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A	DYNC2H1 VPS13C SPTAN1 NCAPH2 URB2 ATP11B GREB1 ATM	7.31e-06	197	115	8	6217_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A	USP34 RASA2 DYNC2H1 NCAPH2 ATP11B KLHL36 PIK3CD SSH3	7.59e-06	198	115	8	6500_DN
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	KIF1A NCAPH2 ORC5 ARIH2 TLR5 FUT4 CABIN1 PLXNA1	8.16e-06	200	115	8	3577_DN
Drug	phenyltriethoxysilane	GLUD1 GLUD2	2.53e-05	2	115	2	CID000013075
Drug	G-3SH	GLUD1 GLUD2	2.53e-05	2	115	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	2.53e-05	2	115	2	CID006455327
Drug	methylmercuric bromide	GLUD1 GLUD2	2.53e-05	2	115	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	2.53e-05	2	115	2	CID000068137
Drug	x 1 s	GLUD1 GLUD2	2.53e-05	2	115	2	CID000409694
Drug	cyclohexanone	PGR GLUD1	2.53e-05	2	115	2	ctd:C036468
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; HL60; HT_HG-U133A	URB2 LRP8 FRY GALNT11 PIK3CD FUT4 TCFL5	4.37e-05	185	115	7	1833_DN
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	USP34 ITIH5 PGR FRMD4A GREB1 ATM AGBL2	5.00e-05	189	115	7	2231_UP
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; HL60; HT_HG-U133A	NOL6 PDZD7 NCAPH2 URB2 RET THEM6 NOC4L	5.53e-05	192	115	7	2507_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	USP34 CPD NCAPH2 GREB1 ATM FUT4 PLXNA1	5.53e-05	192	115	7	3252_DN
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PLXNA3 DYNC2H1 SPTAN1 NCAPH2 TLR5 ATM CABIN1	5.71e-05	193	115	7	5315_UP
Drug	Pivampicillin [33817-20-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PLXNA3 USP34 ZSCAN12 RASA2 NCAPH2 ATM PLXNA1	5.90e-05	194	115	7	3506_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	NCAPH2 WDR19 THEM6 ARIH2 NOC4L SMARCD3 ESPL1	5.90e-05	194	115	7	1822_DN
Drug	leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA	PDE8A VPS13C URB2 ARIH2 UGGT2 ATM CABIN1	6.09e-05	195	115	7	1108_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A	NCKAP1 PPP2R2D DYNC2H1 URB2 SSH3 CABIN1 SEC14L1	6.09e-05	195	115	7	5297_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	LAMA4 NCAPH2 ORC5 FRMD4A FUT4 CABIN1 CDON	6.09e-05	195	115	7	3941_DN
Drug	Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A	PLXNA3 ABCA2 SPTAN1 ZKSCAN5 ZBTB39 SSH3 CABIN1	6.29e-05	196	115	7	4469_DN
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	KIF1A NCAPH2 WDR19 ARIH2 TLR5 CABIN1 PLXNA1	6.50e-05	197	115	7	7185_DN
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	PLXNA3 USP34 KIF1A SPTAN1 NCAPH2 SSH3 ATM	6.50e-05	197	115	7	3300_DN
Drug	glyceollin	PGR GLUD1 GLUD2	6.70e-05	16	115	3	CID000162807
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A	USP34 SPTAN1 CPD NCAPH2 ZBTB39 GREB1 ATM	6.71e-05	198	115	7	6464_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ABCA2 SPTAN1 ZKSCAN5 FRMD4A PTPN14 ARIH2 SMARCD3	6.71e-05	198	115	7	1689_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A	SPTAN1 NOL6 KDM3B FRY ZBTB39 ARIH2 SEC14L1	6.71e-05	198	115	7	1158_DN
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	USP34 KIF1A WDR19 KLHL36 ARIH2 CABIN1 SEC14L1	6.71e-05	198	115	7	1690_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	USP34 NCAPH2 PGR PTPN14 KLHL36 ATM FUT4	6.71e-05	198	115	7	3264_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	NCAPH2 ORC5 PIK3CD SSH3 ARIH2 GREB1 ATM	6.93e-05	199	115	7	6458_DN
Drug	11-mercapto-1-undecanol	MREG TRIM37	7.56e-05	3	115	2	CID000261824
Drug	lenthionine	GLUD1 GLUD2	7.56e-05	3	115	2	CID000067521
Drug	mildiomycin	GLUD1 GLUD2	7.56e-05	3	115	2	CID000125665
Drug	methoxyethylmercury	GLUD1 GLUD2	7.56e-05	3	115	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	7.56e-05	3	115	2	CID000600674
Drug	methylmercuric iodide	GLUD1 GLUD2	7.56e-05	3	115	2	CID000067347
Drug	d-arabino-3-hexulose 6-phosphate	CPD GLUD1 GLUD2	8.11e-05	17	115	3	CID000193886
Drug	methyl benzoquate	GLUD1 GLUD2	1.51e-04	4	115	2	CID000026383
Drug	pentenoic acid	GLUD1 GLUD2	1.51e-04	4	115	2	CID000012299
Drug	alpha-ketoglutaramate	GLUD1 GLUD2	1.51e-04	4	115	2	CID000000048
Drug	chloro acetate	FUT4 TCFL5	1.51e-04	4	115	2	CID012616564
Drug	ureidoglycine	GLUD1 GLUD2	1.51e-04	4	115	2	CID000439649
Drug	Ivin	GLUD1 GLUD2	1.51e-04	4	115	2	CID000014083
Drug	8-BDB-TADP	GLUD1 GLUD2	1.51e-04	4	115	2	CID000130791
Drug	cadina-3,9-diene	GLUD1 GLUD2	1.51e-04	4	115	2	CID000010657
Drug	AC1L9CUQ	GLUD1 GLUD2	1.51e-04	4	115	2	CID000442451
Drug	luxabendazole	GLUD1 GLUD2	1.51e-04	4	115	2	CID000072019
Drug	N-butylmaleimide	GLUD1 GLUD2	1.51e-04	4	115	2	CID000239780
Drug	alpha-methylglutamate	GLUD1 GLUD2	1.51e-04	4	115	2	CID000095440
Drug	2b E2	GLUD1 GLUD2	1.51e-04	4	115	2	CID005327076
Drug	glycyl-l-glutamine	GLUD1 GLUD2 TRIM37	2.35e-04	24	115	3	CID000123913
Drug	bathocuproine	GLUD1 GLUD2	2.50e-04	5	115	2	CID000065149
Drug	AC1NRA4I	GLUD1 GLUD2	2.50e-04	5	115	2	CID005287695
Drug	isosteviol lactone	GLUD1 GLUD2	2.50e-04	5	115	2	CID000401559
Drug	1-pheg	GLUD1 GLUD2	2.50e-04	5	115	2	CID000152041
Drug	5'-FSBAzA	GLUD1 GLUD2	2.50e-04	5	115	2	CID000130430
Drug	adenine N1-oxide	GLUD1 GLUD2	2.50e-04	5	115	2	CID000093557
Drug	choline sulfate	GLUD1 GLUD2	2.50e-04	5	115	2	CID000000485
Drug	l-413	GLUD1 GLUD2	2.50e-04	5	115	2	CID000012475
Drug	3-aminopicolinate	GLUD1 GLUD2	2.50e-04	5	115	2	CID000073836
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; HL60; HT_HG-U133A	NOL6 URB2 NOC4L FUT4 CABIN1 PLXNA1	2.92e-04	178	115	6	2977_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	USP34 SPTAN1 WDR19 FRY PIK3CD TLR5	3.10e-04	180	115	6	2639_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	PLXNA3 KIF1A SPTAN1 WDR19 PIK3CD TLR5	3.10e-04	180	115	6	6579_UP
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	SPTAN1 PGR GREB1 CSGALNACT1 CDON SEC14L1	3.39e-04	183	115	6	5221_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	USP34 URB2 LRP8 FRY PIK3CD ATM	3.49e-04	184	115	6	1835_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	DYNC2H1 NCAPH2 ATP11B GREB1 ATM FUT4	3.69e-04	186	115	6	3279_DN
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ABCA2 KIF1A SPTAN1 RET LRP8 CABIN1	3.69e-04	186	115	6	6051_DN
Drug	alpha-monofluoromethylputrescine	GLUD1 GLUD2	3.74e-04	6	115	2	CID000134201
Drug	dimethylmalonate	GLUD1 GLUD2	3.74e-04	6	115	2	CID000007943
Drug	2-methyl-1,2,3,4-tetrahydroisoquinoline	GLUD1 GLUD2	3.74e-04	6	115	2	CID000015362
Drug	lanosol	GLUD1 GLUD2	3.74e-04	6	115	2	CID000078659
Drug	dadAB	GLUD1 GLUD2	3.74e-04	6	115	2	CID000022626
Drug	N-methylhydantoin	GLUD1 GLUD2	3.74e-04	6	115	2	CID000069217
Drug	diazonium-1-H-tetrazole	GLUD1 GLUD2	3.74e-04	6	115	2	CID000188312
Drug	AC1L448Y	GLUD1 GLUD2	3.74e-04	6	115	2	CID000200389
Drug	2-BDB-TAMP	GLUD1 GLUD2	3.74e-04	6	115	2	CID000127220
Drug	Emid	GLUD1 GLUD2	3.74e-04	6	115	2	CID000074798
Drug	AC1L8SA5	GLUD1 GLUD2	3.74e-04	6	115	2	CID000407285
Drug	isodiazinon	GLUD1 GLUD2	3.74e-04	6	115	2	CID000133913
Drug	15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A	ABCA2 NCAPH2 URB2 THEM6 FUT4 CABIN1	3.80e-04	187	115	6	6190_DN
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	USP34 ZSCAN12 RET TLR5 GREB1 CABIN1	3.80e-04	187	115	6	5598_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	NOL6 CPD RET MREG GREB1 ATM	4.13e-04	190	115	6	7405_DN
Drug	Dichlorodiphenyldichloroethane	LRRC2 RET PGR	4.17e-04	29	115	3	ctd:D003632
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A	PLXNA3 ABCA2 SPTAN1 ZKSCAN5 ORC5 ATM	4.37e-04	192	115	6	7364_UP
Drug	Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A	ZSCAN12 ZBTB39 KLHL36 TLR5 ATM CABIN1	4.62e-04	194	115	6	6467_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	KIF1A DYNC2H1 NCAPH2 URB2 ARIH2 ATM	4.62e-04	194	115	6	6958_DN
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A	ZSCAN12 NCAPH2 ZBTB39 SSH3 ARIH2 CABIN1	4.62e-04	194	115	6	5674_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	PDE8A KIF1A NCAPH2 NLGN1 BCAR3 CDON	4.74e-04	195	115	6	2681_DN
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ZSCAN12 RET PGR ARIH2 TLR5 CABIN1	4.74e-04	195	115	6	4972_UP
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ABCA2 NCKAP1 NCAPH2 SSH3 GREB1 CABIN1	4.74e-04	195	115	6	5299_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A	USP34 KIF1A LAMA4 ZKSCAN5 SSH3 SMARCD3	4.74e-04	195	115	6	2113_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	USP34 RASA2 SPTAN1 TMEM39B NCAPH2 SSH3	4.74e-04	195	115	6	1665_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; HL60; HT_HG-U133A	LAMA4 KLHL36 SSH3 ARIH2 PLXNA1 SEC14L1	4.74e-04	195	115	6	2460_DN
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A	KIF1A SPTAN1 NCAPH2 ORC5 SSH3 PLXNA1	4.74e-04	195	115	6	4947_DN
Disease	migraine without aura, susceptibility to, 4, age at onset	NRAP NOL6	1.53e-05	2	116	2	EFO_0004847, MONDO_0011847
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	4.58e-05	3	116	2	DOID:885 (biomarker_via_orthology)
Disease	migraine disorder, age at onset	NRAP NOL6	4.58e-05	3	116	2	EFO_0004847, MONDO_0005277
Disease	fat intake measurement	NRAP NOL6 MLXIPL	8.63e-05	22	116	3	EFO_0010809
Disease	Jeune thoracic dystrophy	DYNC2H1 WDR19	9.15e-05	4	116	2	cv:C0265275
Disease	synucleinopathy (biomarker_via_orthology)	KIF1A DCTN2	9.15e-05	4	116	2	DOID:0050890 (biomarker_via_orthology)
Disease	Galloway-Mowat syndrome (is_implicated_in)	NUP107 NUP133	1.52e-04	5	116	2	DOID:0080694 (is_implicated_in)
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	NUP107 NUP205 NUP133	2.22e-04	30	116	3	C1868672
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	2.27e-04	6	116	2	DOID:1825 (biomarker_via_orthology)
Disease	Hyperammonemia	GLUD1 TLR5	3.18e-04	7	116	2	C0220994
Disease	glypican-1 measurement	NRAP NOL6	3.18e-04	7	116	2	EFO_0801649
Disease	cerebrospinal fluid clusterin measurement	ABCA13 NCAPH2 CSMD1	3.53e-04	35	116	3	EFO_0007657
Disease	parasitemia measurement	FRMD4A COL14A1 CSMD1	4.17e-04	37	116	3	EFO_0005528
Disease	Galloway Mowat syndrome	NUP107 NUP133	4.22e-04	8	116	2	C0795949
Disease	Jeune thoracic dystrophy	DYNC2H1 WDR19	8.23e-04	11	116	2	C0265275
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	PPP2R2D PPP2R2A	9.86e-04	12	116	2	DOID:1441 (implicated_via_orthology)
Disease	Renal dysplasia and retinal aplasia (disorder)	WDR19 SCLT1	9.86e-04	12	116	2	C0403553
Disease	FVC change measurement, response to placebo	KIF1A ORC5	1.16e-03	13	116	2	EFO_0008344, EFO_0010339
Disease	factor VII activating protease measurement	NRAP NOL6 KLHL36	1.34e-03	55	116	3	EFO_0009368
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	1.56e-03	15	116	2	DOID:13413 (biomarker_via_orthology)
Disease	adverse effect, response to xenobiotic stimulus	ABCA2 NLGN1 COL14A1	1.64e-03	59	116	3	EFO_0009658, GO_0009410
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	PIK3CD ATM	1.77e-03	16	116	2	C0334634
Disease	bitter alcoholic beverage consumption measurement	ORC5 MLXIPL CSMD1 AGBL2	1.91e-03	133	116	4	EFO_0010092
Disease	sphingomyelin 22:0 measurement	HEATR1 CSMD1	2.78e-03	20	116	2	EFO_0010395
Disease	Alzheimer disease	ZSCAN12 FRMD4A FMN2 NOC4L CSMD1 CDON KLHL4	3.11e-03	485	116	7	MONDO_0004975
Disease	triacylglycerol 58:9 measurement	LRRC2 CSMD1	3.36e-03	22	116	2	EFO_0010443

Protein segments in the cluster

Peptide	Gene	Start	Entry
WIYIDNILHSRKLQN	URB2	71	Q14146
NQLYLRWSTDHATSK	CSMD1	2406	Q96PZ7
LQEWEEQHRNYVSSL	CSGALNACT1	61	Q8TDX6
TYLSADDLRINLWHL	PPP2R2A	191	P63151
RLEKTWTALRHQYTQ	BCAR3	661	O75815
RILSDTWDQNRVIHY	FBXW10	406	Q5XX13
VWLDVINHLYLLSNS	ABCA13	1396	Q86UQ4
ETYLSADDLRINLWH	PPP2R2D	196	Q66LE6
WKLHLTERADFQYSQ	ABHD17A	66	Q96GS6
VNFHWQVSEILDRYK	ARIH2	96	O95376
QSKVHQLYETIQRWS	DCTN2	306	Q13561
REWDKQEILYQTHLI	DEUP1	151	Q05D60
TSDLEQNWSLQDHYR	CCDC14	186	Q49A88
NSASKDYTLHLWNLL	NWD1	926	Q149M9
VNVLRTDSSHQAWYL	RASA2	276	Q15283
YWENTLHTLKQRQLT	NUP107	296	P57740
YIATIHSRLQDSQLW	NUP205	306	Q92621
RILSDTWDQNRVIHY	FBXW10B	406	O95170
DRQQLYWELSQLTHS	MUC16	13251	Q8WXI7
EQLYWELSQLTHNIT	MUC16	13721	Q8WXI7
HAYSWDINRALKENI	NUP133	306	Q8WUM0
KVYRWADHSSTVLQR	KLHL36	21	Q8N4N3
SWRESHLTEIRQYQQ	GREB1	466	Q4ZG55
NINLREESDWHYLQL	GREB1	1381	Q4ZG55
NHIERLWSYLTTKEL	ITIH5	571	Q86UX2
NALHLSDKVYRNSWE	NRAP	1506	Q86VF7
SQHLDYITEKLWRNA	FUT4	416	P22083
WSHLELLRKYVLASQ	GABPA	241	Q06546
NSRGNTWSRKHLYLE	LIPJ	86	Q5W064
KRHIDYSRQQISLFW	IL12RB2	331	Q99665
LHELKNLTQYSWLLD	AK3	76	Q9UIJ7
WKRLNTLAHYQVTDG	PLXNA1	1581	Q9UIW2
WKRLNSLAHYQVTDG	PLXNA3	1556	P51805
ITRSQSYLTLWEEKQ	PDZD7	431	Q9H5P4
STLRSWLQIIEANYH	PDE8A	536	O60658
WIYNEEHELVLNSLL	GALNT11	521	Q8NCW6
SHSVQFLRALWEKTQ	VEPH1	636	Q14D04
RYNTWVLQDTVLESH	NOL6	296	Q9H6R4
PIHDQSWYLDQTLRK	KDM3B	1646	Q7LBC6
SLKEQTHLREWYISN	LRRC2	116	Q9BYS8
THLREWYISNTLIQI	LRRC2	121	Q9BYS8
EKLSYFEHNLETWRQ	GNL1	166	P36915
KHYEEQQAWNITLRI	NLRP4	61	Q96MN2
EHYRANKVNLWLELV	NLGN1	636	Q8N2Q7
HYNGSSLLQWKSVRL	HECTD4	2046	Q9Y4D8
IEKYDLRTNSWLHIG	KLHL4	446	Q9C0H6
WYLETLLRQVSNGHI	NCKAP1	791	Q9Y2A7
NLHIDDQITLIQYSW	PGR	741	P06401
DELRQWYQRSTASHK	FRMD4A	926	Q9P2Q2
VLYDSWVKQLRSHNV	DNAH1	3171	Q9P2D7
AWVKANIQYSHVLER	DYNC2H1	3091	Q8NCM8
ASHLDYLVLEWLNLQ	ATM	1211	Q13315
DLLRSQLYWTHQKVT	ESPL1	861	Q14674
YWNRENSGSKLLVHL	CD101	851	Q93033
RYLEEHSAQQVDLIW	CABIN1	961	Q9Y6J0
KDIRSPEQHYWVTLN	GCNT7	306	Q6ZNI0
NRSIHEVILKNITWY	DYM	411	Q7RTS9
RNTIREYEWIHSQTK	CHD2	571	O14647
EWLKNLNHVSYGRLT	GLUD1	441	P00367
LRYNVISHDSIQISW	COL14A1	36	Q05707
IRGKWLEHSTENYLI	CDON	156	Q4KMG0
LTNLGQSTEYRHIWS	CPD	956	O75976
QSTEYRHIWSLEISN	CPD	961	O75976
THYAQVWLNISAEIR	ABCA2	486	Q9BZC7
TLRTDLYTNKHTQWF	AGBL2	291	Q5U5Z8
HLSARYLLQETWLEK	ERO1A	261	Q96HE7
ELWAHYVEELNSTQR	HEATR1	766	Q9H583
IEKYVQSVHWREALN	FRY	2271	Q5TBA9
HAILDLVQYLKWRSA	GRIK3	161	Q13003
LYWTRIQLHSKRDSS	FMN2	1296	Q9NZ56
YLHETWTQGNRLSTV	ERVFC1	36	P60507
SLTWRKQHQVDYILE	SEC14L1	301	Q92503
LESSLWELQALQRHY	NOC4L	431	Q9BVI4
AWLKRDAESIHQYLL	NPEPPS	896	P55786
EWLKNLNHVSYGRLT	GLUD2	441	P49448
ATHYWTLEKLRQRLD	KIF1A	796	Q12756
QRLYWVDSKLHQLSS	LRP8	596	Q14114
YELLSQAESWQRLHN	LAMA4	451	Q16363
NYWSISSRHVLLQEE	GOLM2	31	Q6P4E1
KSRDQHWYITQLEAA	TRIM37	411	O94972
SYLWRLEKEEQQTLS	TRIM38	196	O00635
AELDRWLYHLEKQTA	PLEKHN1	176	Q494U1
LQHWISYNEASSQLL	THEM6	181	Q8WUY1
TARKIREHLSYEDWN	SLC9C1	1006	Q4G0N8
SVNSHIYQRWKDLLQ	SAMD9L	581	Q8IVG5
YQRLWESSHATLQEL	IQCA1L	6	A6NCM1
EWQKLNYDIHTLRQV	MREG	86	Q8N565
QTVYLREISSSQWEK	ORC5	266	O43913
LATQTYIRWQELLTH	FAM178B	651	Q8IXR5
YLQRKLFSQNTVHWL	FASTKD3	646	Q14CZ7
LLSGQERTVWHLQYT	PTPN14	1061	Q15678
ALWQYVKTNRLQDSH	SMARCD3	286	Q6STE5
HDWTRKSQQYDLNAL	SEMG2	76	Q02383
AKQWQSVIRIYLDHL	WDR19	921	Q8NEZ3
VHTLRQTSLAWLDQY	MLXIPL	791	Q9NP71
LTWASHYQERLNSEQ	SSH3	226	Q8TE77
SQELVQLWNDIHYRL	ANHX	91	E9PGG2
VLYWTHVKEQLETLR	NCAPH2	391	Q6IBW4
TAIKQGYEDWLRHNS	ATP11B	101	Q9Y2G3
ENDWHRVYLVRKLSS	RNF213	4271	Q63HN8
ELSQLRIYSVNAHWE	UHRF1BP1L	146	A0JNW5
LYSLLRSEKWNHTLS	TMEM39A	436	Q9NV64
AFHQWIQETRTYLLD	SPTAN1	2216	Q13813
IILSRDNTTKYNSEW	PIEZO2	2616	Q9H5I5
NLSTIKQLLWHRAQY	PIK3CD	41	O00329
EAKLEHWYITGLRQQ	VPS13C	576	Q709C8
WQTVSQELDRLHKLY	SCLT1	151	Q96NL6
YQNRKDLSSTLWHAA	PKHD1L1	3396	Q86WI1
YLNRSLDHSSWEKLS	RET	96	P07949
ETKFFTQWQLTLHRR	ZBTB39	406	O15060
WHQDQALSSSIYLLR	ZSWIM2	21	Q8NEG5
RYKVLEQQWISHTFD	UBR3	1861	Q6ZT12
EEHWARLQRYSLSLQ	WDR93	666	Q6P2C0
ETTRISHWKDYVNVR	TRIM49D1	161	C9J1S8
NTLIQYHSIEEDKWR	STARD4	16	Q96DR4
WEYTRQQLLSHGDTK	TARBP1	1606	Q13395
DLRAEVTHWYENLQK	USP34	1236	Q70CQ2
WILRLHQGKSEDIYQ	UGGT2	1141	Q9NYU1
WVQNALLKHLDTQYS	TLR5	706	O60602
QWTTAFLKYIQERHG	TCFL5	441	Q9UL49
YTTRQDWDLRKNNTH	ZSCAN12	26	O43309
WQHIQDYTLSRKQLF	ZFC3H1	1201	O60293
SLTQHSWQSLKDRYL	TERF2IP	171	Q9NYB0
EWGHLDQSQKSLYRD	ZKSCAN5	231	Q9Y2L8
RDYLLTLRETWKQHT	TMEM39B	236	Q9GZU3